Latest S-1 registration statements

Hennessy Capital Investment Corp. VII, a newly formed blank check company, aims to raise $175 million through an IPO to target a business combination in the industrial technology and energy transition sectors.

Firefly Neuroscience is registering for resale 2,559,645 shares of common stock by selling securityholders, including shares from private placements, warrant exercises, and conversions.

ConnectM Technology Solutions has filed a registration statement for the potential resale of up to 51.7 million shares of its common stock and various warrants by existing security holders.

Marwynn Holdings, a supply chain company focused on food, beverage, and home improvement products, seeks to raise capital through an initial public offering.

Allurion Technologies is seeking to raise capital through an offering of common stock, pre-funded warrants, and common stock purchase warrants.

Venture Global, a rapidly growing LNG company, files for an IPO to support its continued expansion and capitalize on the increasing global demand for liquefied natural gas.

Flowco Holdings Inc. announces its initial public offering to fund growth in production optimization, artificial lift, and methane abatement solutions.

FibroBiologics has filed an amendment to its registration statement for the resale of up to 41,489,581 shares of common stock by YA II PN, LTD.

Sharps Technology Inc. plans to offer up to 6,726,457 units, each including common stock and warrants, or pre-funded units as an alternative.

Aclarion Inc. is set to offer shares of common stock along with Series A and B warrants, and pre-funded warrants in a new public offering.

Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an amendment to its Form S-1 registration statement for a direct listing on the NYSE, aiming to improve patient outcomes through innovative drug delivery systems.

Coeptis Therapeutics files an S-1 registration statement for the resale of up to 3,919,349 shares of common stock by selling stockholders, including shares issuable under a Standby Equity Purchase Agreement with Yorkville.

Expectation Acquisition Corporation, a blank check company, files an amendment to its Form S-1 registration statement for a $60 million initial public offering.

Veea Inc. files an amendment to its Form S-1 registration statement, detailing an equity line of credit agreement with White Lion Capital and recent business developments.

Veea Inc. has filed an amendment to its S-1 registration statement to allow for the resale of common stock and warrants by existing security holders.

Metsera, a clinical-stage biotech, is going public to fund its innovative pipeline of injectable and oral NuSH analog peptides targeting obesity and overweight, seeking to overcome limitations of existing treatments.

Nexalin Technology has filed an amendment to its S-1 registration statement to allow selling stockholders to resell up to 2,798,613 shares of common stock.

Reliance Global Group launches a unit offering, including common stock or pre-funded warrants and warrants, to finance the acquisition of Spetner Associates and for general corporate purposes.

New Era Helium Inc. has filed a registration statement for the resale of 50.8 million shares of common stock and 230,746 private warrants by existing shareholders.

Live Oak Acquisition Corp. V, a blank check company, has filed for a $200 million IPO to pursue a merger, share exchange, asset acquisition, or similar business combination.

Applied DNA Sciences has filed an amendment to its Form S-1 registration statement, pertaining to the resale of up to 41,640,625 shares of common stock issuable upon the exercise of outstanding warrants.

Elite Performance Holding Corp. has filed an amendment to its registration statement for a proposed initial public offering of 1,625,000 shares and a concurrent resale of 1,160,000 shares.

CH4 Natural Solutions Acquisition Corporation, a newly formed blank check company, aims to raise $250 million in an initial public offering to pursue a business combination in the agriculture and traditional energy sectors, focusing on methane mitigation.

Alpha One Inc. has filed an amendment to its S-1 registration statement to register 10 million shares of common stock for sale by existing shareholders.

Origin Investment Corp I, a newly formed blank check company, has filed an S-1 registration statement for an initial public offering of 6 million units at $10.00 each, aiming to effect a business combination primarily with target businesses in Asia's high-growth sectors.

International Land Alliance, a residential land development company, is planning a public offering of its common stock to facilitate a listing on the Nasdaq Capital Market.

Toppoint Holdings Inc. has filed an amendment to its S-1 registration statement primarily to include an updated consent from its independent auditor, TAAD, LLP.

Falcons Beyond Global, Inc. is offering $100 million of Class A common stock, with an underwriter option for an additional $15 million, to fund general corporate purposes.

Apimeds Pharmaceuticals US, Inc. has filed an amendment to its S-1 registration statement, indicating progress towards its initial public offering and plans to list on the NYSE American under the symbol APUS.

Cosmos Health Inc. is offering up to 10,714,286 shares of common stock, pre-funded warrants, and common warrants in a best-efforts offering.